$NBY Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovaBay Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NovaBay Pharmaceuticals, Inc.. Get notifications about new insider transactions in NovaBay Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 07 2021 | NBY | NovaBay Pharmaceut ... | Jones Andrew D. | CFO | Payment of Exercise | F | 0.79 | 77,994 | 61,834 | 82,006 | 160 K to 82 K (-48.75 %) |
Aug 24 2020 | NBY | NovaBay Pharmaceut ... | Xu Wang | NEO - Sr Mgr and Co ... | Option Exercise | A | 0.99 | 75,000 | 74,250 | 75,000 | |
Aug 24 2020 | NBY | NovaBay Pharmaceut ... | Jones Andrew D. | CFO | Option Exercise | A | 0.99 | 25,000 | 24,750 | 25,000 | |
Aug 24 2020 | NBY | NovaBay Pharmaceut ... | Hall Justin | CEO and GC | Option Exercise | A | 0.99 | 350,000 | 346,500 | 350,000 | |
Aug 19 2020 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Option Exercise | X | 0.30 | 20,000 | 6,000 | 0 | |
Aug 19 2020 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Sell | S | 1.35 | 20,000 | 27,000 | 0 | 20 K to 0 (-100.00 %) |
Aug 19 2020 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Grant | A | 0.30 | 20,000 | 6,000 | 20,000 | 0 to 20 K |
Aug 04 2020 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Sell | S | 1.23 | 1,302,350 | 1,601,891 | 4,000,000 | 5.3 M to 4 M (-24.56 %) |
May 29 2020 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Option Exercise | A | 0.89 | 20,000 | 17,800 | 20,000 | |
May 29 2020 | NBY | NovaBay Pharmaceut ... | Zheng Yenyou | Director | Option Exercise | A | 0.89 | 20,000 | 17,800 | 20,000 | |
May 29 2020 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | Director | Option Exercise | A | 0.89 | 20,000 | 17,800 | 20,000 | |
May 29 2020 | NBY | NovaBay Pharmaceut ... | Wang Xiaopei | Director | Option Exercise | A | 0.89 | 20,000 | 17,800 | 20,000 | |
May 29 2020 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 0.89 | 20,000 | 17,800 | 20,000 | |
Oct 30 2019 | NBY | NovaBay Pharmaceut ... | Zavodnick Todd Erik | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
Oct 28 2019 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
Oct 28 2019 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
Oct 28 2019 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
Oct 28 2019 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
Oct 28 2019 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 0.30 | 20,000 | 6,000 | 20,000 | |
Aug 06 2019 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Grant | A | 0.00 | 167,938 | 0 | 1,156,883 | 988.9 K to 1.2 M (+16.98 %) | |
Jun 13 2019 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Sell | S | 3.84 | 380,954 | 1,462,863 | 5,302,350 | 5.7 M to 5.3 M (-6.70 %) |
Jun 13 2019 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Hong Kong) Co ... | 10% Owner | Sell | S | 4.04 | 24,326 | 98,277 | 5,188,421 | 5.2 M to 5.2 M (-0.47 %) |
Jun 13 2019 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Sell | S | 3.84 | 380,954 | 1,462,863 | 5,302,350 | 5.7 M to 5.3 M (-6.70 %) |
Jun 13 2019 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Hong Kong) Co ... | 10% Owner | Sell | S | 4.04 | 24,326 | 98,277 | 5,188,421 | 5.2 M to 5.2 M (-0.47 %) |
Jun 13 2019 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Sell | S | 4.04 | 15,873 | 64,127 | 0 | 15.9 K to 0 (-100.00 %) |
Jun 13 2019 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Sell | S | 2.03 | 47,619 | 96,667 | 0 | 47.6 K to 0 (-100.00 %) |
Jun 12 2019 | NBY | NovaBay Pharmaceut ... | Raleigh Jason Philip | Interim CFO and Tre ... | Option Exercise | X | 2.35 | 9,750 | 22,913 | 0 | |
Jun 12 2019 | NBY | NovaBay Pharmaceut ... | Raleigh Jason Philip | Interim CFO and Tre ... | Option Exercise | X | 2.20 | 23,405 | 51,491 | 0 | |
Jun 12 2019 | NBY | NovaBay Pharmaceut ... | Hall Justin | SVP, General Counse ... | Option Exercise | X | 2.02 | 47,500 | 95,950 | 0 | |
Oct 11 2018 | NBY | NovaBay Pharmaceut ... | McGovern John Joseph | Int Pres, CEO, CFO ... | Option Exercise | A | 1.45 | 250,000 | 362,500 | 440,000 | |
Jun 04 2018 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 35,244 | |
Jun 04 2018 | NBY | NovaBay Pharmaceut ... | Ma Yonghao | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 43,629 | |
Jun 04 2018 | NBY | NovaBay Pharmaceut ... | Liu Yanbin | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 20,000 | |
Jun 04 2018 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 25,248 | |
Jun 04 2018 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 2.20 | 20,000 | 44,000 | 62,697 | |
Jun 01 2018 | NBY | NovaBay Pharmaceut ... | Hall Justin | SVP, General Counse ... | Option Exercise | A | 2.20 | 190,000 | 418,000 | 345,710 | |
Jun 01 2018 | NBY | NovaBay Pharmaceut ... | McGovern John Joseph | CFO and Treasurer | Option Exercise | A | 2.20 | 90,000 | 198,000 | 190,000 | |
Jan 08 2018 | NBY | NovaBay Pharmaceut ... | STUART LEWIS J | Chief Commercial Of ... | Option Exercise | A | 3.42 | 10,000 | 34,200 | 10,000 | |
Jan 08 2018 | NBY | NovaBay Pharmaceut ... | STUART LEWIS J | Chief Commercial Of ... | Option Exercise | A | 3.42 | 100,000 | 342,000 | 100,000 | |
Sep 18 2017 | NBY | NovaBay Pharmaceut ... | Hall Justin | SVP, General Counse ... | Option Exercise | X | 2.78 | 20,000 | 55,600 | 278,160 | |
Aug 01 2017 | NBY | NovaBay Pharmaceut ... | McGovern John Joseph | CFO and Treasurer | Option Exercise | A | 3.80 | 100,000 | 380,000 | 100,000 | |
Jul 07 2017 | NBY | NovaBay Pharmaceut ... | Li Xinzhou | Director | Option Exercise | A | 3.75 | 5,248 | 19,680 | 5,248 | |
Jun 06 2017 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 2.35 | 250,000 | 587,500 | 250,000 | |
Jan 26 2017 | NBY | NovaBay Pharmaceut ... | Hall Justin | SVP, General Counse ... | Option Exercise | A | 3.60 | 143,000 | 514,800 | 278,160 | |
Jan 26 2017 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 3.60 | 116,000 | 417,600 | 310,788 | |
Jan 26 2017 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 3.60 | 238,609 | 858,992 | 936,857 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Option Exercise | A | 3.24 | 15,245 | 49,394 | 15,245 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | LIU XIAOYAN | Director | Option Exercise | A | 3.24 | 15,245 | 49,394 | 15,245 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Ma Yonghao | Director | Option Exercise | A | 3.24 | 33,699 | 109,185 | 37,002 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Zavodnick Todd Erik | Director | Option Exercise | A | 3.24 | 22,359 | 72,443 | 33,699 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 3.24 | 23,883 | 77,381 | 59,769 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 3.24 | 25,916 | 83,968 | 67,097 | |
Jan 04 2017 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 3.24 | 25,916 | 83,968 | 67,097 | |
Oct 11 2016 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Buy | X | 3.15 | 126,985 | 400,003 | 3,983,304 | 3.9 M to 4 M (+3.29 %) |
Oct 04 2016 | NBY | NovaBay Pharmaceut ... | Ma Yonghao | Director | Option Exercise | A | 3.99 | 3,303 | 13,179 | 3,303 | |
Oct 04 2016 | NBY | NovaBay Pharmaceut ... | Zavodnick Todd Erik | Director | Option Exercise | A | 3.99 | 3,303 | 13,179 | 14,396 | |
Oct 03 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Buy | X | 1.91 | 273,447 | 522,284 | 988,945 | 715.5 K to 988.9 K (+38.22 %) |
Oct 03 2016 | NBY | NovaBay Pharmaceut ... | WU MIJIA | Director | Buy | X | 3.15 | 15,873 | 50,000 | 47,619 | 31.7 K to 47.6 K (+50.00 %) |
Sep 26 2016 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Buy | X | 1.91 | 968,587 | 1,850,001 | 3,856,319 | 2.9 M to 3.9 M (+33.54 %) |
Sep 26 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | X | 1.91 | 1,308,902 | 2,500,003 | 5,188,421 | 3.9 M to 5.2 M (+33.74 %) |
Sep 26 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | X | 1.81 | 181,300 | 328,153 | 3,879,519 | 3.7 M to 3.9 M (+4.90 %) |
Aug 02 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | A | 1.91 | 654,451 | 1,250,001 | 1,490,202 | |
Aug 02 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Grant | A | 1.91 | 1,308,901 | 2,500,001 | 3,698,219 | 2.4 M to 3.7 M (+54.78 %) |
Aug 02 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 1.91 | 130,890 | 250,000 | 273,447 | |
Aug 02 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Grant | A | 1.91 | 261,780 | 500,000 | 715,498 | 453.7 K to 715.5 K (+57.70 %) |
Jul 01 2016 | NBY | NovaBay Pharmaceut ... | Zavodnick Todd Erik | Director | Option Exercise | A | 2.58 | 11,093 | 28,620 | 0 | |
Jun 09 2016 | NBY | NovaBay Pharmaceut ... | Hall Justin | General Counsel | Option Exercise | A | 2.78 | 130,000 | 361,400 | 135,160 | |
Jun 08 2016 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 2.78 | 160,000 | 444,800 | 194,788 | |
Jun 08 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | CEO | Option Exercise | A | 2.78 | 675,000 | 1,876,500 | 698,248 | |
May 16 2016 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Option Exercise | A | 1.91 | 968,587 | 1,850,001 | 1,095,572 | |
May 16 2016 | NBY | NovaBay Pharmaceut ... | Fu Jian Ping | 10% Owner | Grant | A | 1.91 | 1,937,173 | 3,700,000 | 2,887,732 | 950.6 K to 2.9 M (+203.79 %) |
May 13 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | A | 1.91 | 654,451 | 1,250,001 | 835,751 | |
May 13 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Grant | A | 1.91 | 1,308,901 | 2,500,001 | 2,389,318 | 1.1 M to 2.4 M (+121.15 %) |
May 13 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 1.91 | 130,890 | 250,000 | 142,557 | |
May 13 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Grant | A | 1.91 | 261,780 | 500,000 | 453,718 | 191.9 K to 453.7 K (+136.39 %) |
Mar 09 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.00 | 58,692 | 0 | 58,692 | |
Mar 09 2016 | NBY | NovaBay Pharmaceut ... | Hall Justin | General Counsel | Option Exercise | A | 0.00 | 5,000 | 0 | 2,400 | |
Feb 26 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Grant | A | 1.91 | 125,387 | 239,489 | 133,246 | 7.9 K to 133.2 K (+1,595.46 %) |
Feb 26 2016 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Grant | A | 1.91 | 696,590 | 1,330,487 | 1,104,742 | 408.2 K to 1.1 M (+170.67 %) |
Jan 06 2016 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 2.02 | 16,032 | 32,385 | 23,246 | |
Jan 06 2016 | NBY | NovaBay Pharmaceut ... | Radaelli Massimo | Director | Option Exercise | A | 2.02 | 600 | 1,212 | 2,400 | |
Jan 06 2016 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 2.02 | 22,719 | 45,892 | 44,210 | |
Jan 06 2016 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 2.02 | 24,777 | 50,050 | 35,886 | |
Jan 06 2016 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 2.02 | 26,835 | 54,207 | 41,181 | |
Oct 06 2015 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 0.27 | 150,000 | 40,500 | 869,675 | |
Oct 06 2015 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Grant | A | 0.00 | 50,000 | 0 | 142,196 | 92.2 K to 142.2 K (+54.23 %) |
Oct 06 2015 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 0.27 | 100,000 | 27,000 | 474,834 | |
Oct 06 2015 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 0.00 | 25,000 | 0 | 25,000 | |
Oct 06 2015 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 0.27 | 150,000 | 40,500 | 614,725 | |
Aug 21 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.44 | 6,000 | 2,640 | 12,000 | 6 K to 12 K (+100.00 %) |
Aug 21 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.50 | 6,000 | 3,000 | 6,000 | 0 to 6 K |
Jun 16 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.79 | 24,128 | 19,061 | 180,362 | |
Apr 15 2015 | NBY | NovaBay Pharmaceut ... | Hoon Russell A. | Senior Vice Preside ... | Option Exercise | A | 0.00 | 4,515 | 0 | 34,217 | |
Mar 25 2015 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Grant | A | 0.00 | 19,296 | 0 | 19,296 | 0 to 19.3 K |
Mar 25 2015 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Grant | A | 0.00 | 23,986 | 0 | 92,196 | 68.2 K to 92.2 K (+35.16 %) |
Mar 25 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Grant | A | 0.00 | 46,033 | 0 | 3,437,699 | 3.4 M to 3.4 M (+1.36 %) |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | P | 0.65 | 124,999 | 81,249 | 291,665 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | P | 0.60 | 166,666 | 100,000 | 291,665 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Buy | P | 0.60 | 166,666 | 100,000 | 196,466 | 29.8 K to 196.5 K (+559.28 %) |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | P | 0.65 | 124,999 | 81,249 | 291,665 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | P | 0.60 | 166,666 | 100,000 | 291,665 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.60 | 166,666 | 100,000 | 3,391,666 | 3.2 M to 3.4 M (+5.17 %) |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | P | 0.65 | 1,942,500 | 1,262,625 | 4,532,500 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Option Exercise | P | 0.60 | 2,590,000 | 1,554,000 | 4,532,500 | |
Mar 05 2015 | NBY | NovaBay Pharmaceut ... | Pioneer Pharma (Singapore) Pte ... | 10% Owner | Buy | P | 0.60 | 2,590,000 | 1,554,000 | 9,595,656 | 7 M to 9.6 M (+36.97 %) |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | Radaelli Massimo | Director | Option Exercise | A | 0.64 | 15,000 | 9,600 | 45,000 | |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 0.64 | 121,144 | 77,532 | 277,726 | |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 0.64 | 69,368 | 44,396 | 377,156 | |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 0.64 | 92,667 | 59,307 | 156,234 | |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 0.64 | 144,444 | 92,444 | 537,279 | |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | Freiman Paul E. | Director | Option Exercise | A | 0.64 | 121,144 | 77,532 | 358,654 | |
Jan 06 2015 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 0.64 | 15,000 | 9,600 | 301,016 | |
Dec 16 2014 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Buy | P | 0.66 | 10,000 | 6,600 | 23,000 | 13 K to 23 K (+76.92 %) |
Dec 15 2014 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Buy | P | 0.68 | 10,000 | 6,800 | 68,210 | 58.2 K to 68.2 K (+17.18 %) |
Dec 15 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.65 | 50,000 | 32,500 | 0 | -50,000 to 0 (-100.00 %) |
Dec 11 2014 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Buy | P | 0.67 | 10,000 | 6,700 | 58,210 | 48.2 K to 58.2 K (+20.74 %) |
Dec 11 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.60 | 20,000 | 12,000 | 3,175,000 | 3.2 M to 3.2 M (+0.63 %) |
Dec 08 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.65 | 25,000 | 16,250 | 3,155,000 | 3.1 M to 3.2 M (+0.80 %) |
Dec 04 2014 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Sell | S | 0.70 | 20,000 | 14,000 | 0 | 20 K to 0 (-100.00 %) |
Dec 04 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Buy | P | 0.71 | 18,000 | 12,780 | 3,130,000 | 3.1 M to 3.1 M (+0.58 %) |
Dec 03 2014 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Sell | S | 0.69 | 10,000 | 6,900 | 213,680 | 223.7 K to 213.7 K (-4.47 %) |
Sep 30 2014 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 0.75 | 50,000 | 37,500 | 374,834 | |
Sep 30 2014 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 0.75 | 50,000 | 37,500 | 464,725 | |
Sep 30 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 0.75 | 90,000 | 67,500 | 1,015,032 | |
Sep 30 2014 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 0.75 | 60,000 | 45,000 | 719,675 | |
Sep 30 2014 | NBY | NovaBay Pharmaceut ... | Bley Keith R | SVP Product Develop ... | Option Exercise | A | 0.75 | 50,000 | 37,500 | 258,120 | |
Jun 05 2014 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Buy | P | 0.89 | 4,800 | 4,272 | 29,800 | 25 K to 29.8 K (+19.20 %) |
Jun 04 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Gift | G | 0.00 | 5,500 | 0 | 3,112,000 | 3.1 M to 3.1 M (-0.18 %) |
May 21 2014 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Buy | P | 0.88 | 25,000 | 22,000 | 25,000 | 0 to 25 K |
May 14 2014 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Buy | P | 0.99 | 65,065 | 64,414 | 608,156 | 543.1 K to 608.2 K (+11.98 %) |
May 14 2014 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Buy | P | 0.99 | 116,107 | 114,946 | 543,091 | 427 K to 543.1 K (+27.19 %) |
May 14 2014 | NBY | NovaBay Pharmaceut ... | China Pioneer Pharma Holdings ... | 10% Owner | Buy | P | 0.99 | 318,828 | 315,640 | 426,984 | 108.2 K to 427 K (+294.79 %) |
Apr 17 2014 | NBY | NovaBay Pharmaceut ... | Bley Keith R | SVP Product Develop ... | Option Exercise | A | 1.00 | 7,120 | 7,120 | 208,120 | |
Apr 17 2014 | NBY | NovaBay Pharmaceut ... | PAULSON THOMAS J | CFO | Option Exercise | A | 1.00 | 9,866 | 9,866 | 699,675 | |
Apr 17 2014 | NBY | NovaBay Pharmaceut ... | Stroman David W. | SVP, Ophthalmic Pro ... | Option Exercise | A | 1.00 | 5,011 | 5,011 | 324,834 | |
Apr 17 2014 | NBY | NovaBay Pharmaceut ... | WU ROY J | SVP Bus & Corp Deve ... | Option Exercise | A | 1.00 | 7,823 | 7,823 | 414,725 | |
Apr 17 2014 | NBY | NovaBay Pharmaceut ... | Najafi Ramin | Chief Executive Off ... | Option Exercise | A | 1.00 | 10,180 | 10,180 | 925,032 | |
Apr 14 2014 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | M | 0.56 | 52,000 | 29,120 | 234,068 | |
Apr 14 2014 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Buy | M | 0.56 | 52,000 | 29,120 | 213,690 | 161.7 K to 213.7 K (+32.16 %) |
Mar 21 2014 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Option Exercise | M | 0.56 | 9,000 | 5,040 | 191,967 | |
Mar 21 2014 | NBY | NovaBay Pharmaceut ... | Dailley Anthony | Director | Buy | M | 0.56 | 9,000 | 5,040 | 285,259 | 276.3 K to 285.3 K (+3.26 %) |
Jan 31 2014 | NBY | NovaBay Pharmaceut ... | Tufts Robert R. | Director | Option Exercise | A | 1.14 | 30,583 | 34,865 | 191,468 | |
Jan 31 2014 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 1.14 | 14,919 | 17,008 | 286,068 | |
Jan 31 2014 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 1.14 | 33,567 | 38,266 | 63,567 | |
Jan 31 2014 | NBY | NovaBay Pharmaceut ... | McPherson T. Alex | Director | Option Exercise | A | 1.14 | 86,528 | 98,642 | 382,335 | |
Jan 31 2014 | NBY | NovaBay Pharmaceut ... | Maderis Gail J | Director | Option Exercise | A | 1.14 | 61,167 | 69,730 | 267,631 | |
Jan 31 2014 | NBY | NovaBay Pharmaceut ... | Cashion Charles | Director | Option Exercise | A | 1.14 | 31,329 | 35,715 | 307,788 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Radaelli Massimo | Director | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | SIECZKAREK MARK M | Director | Option Exercise | A | 1.25 | 30,000 | 37,500 | 30,000 | |
Jan 09 2014 | NBY | NovaBay Pharmaceut ... | Wicks Tony D.S. | Director | Option Exercise | A | 1.29 | 15,000 | 19,350 | 271,149 |